Trial Profile
Gulf War Illness Inflammation Reduction Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2023
Price :
$35
*
At a glance
- Drugs Prednisone (Primary)
- Indications Persian-gulf-syndrome
- Focus Therapeutic Use
- Acronyms GWIIRT
- Sponsors Minneapolis VA Medical Center
- 07 Apr 2022 Status changed from recruiting to completed.
- 13 Aug 2019 Planned End Date changed from 1 Jan 2020 to 1 Oct 2020.
- 24 Jul 2015 New trial record